Previous studies have provided some evidence, in known breast cancer susceptibility genes BRCA1 [58] and BRCA2 [59], of genetic variants associated with allelic expression differences which could affect the risk of breast cancer in mutation carriers through altering expression levels of the wild-type allele. This evidence concerns the gene BRCA2 and breast cancer.